Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Puma Biotechnology
PBYI
|
+$276M |
| 2 |
Home Depot
HD
|
+$240M |
| 3 |
TE Connectivity
TEL
|
+$232M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$191M |
| 5 |
SHPG
Shire pic
SHPG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$279M |
| 2 |
Meta Platforms (Facebook)
META
|
+$271M |
| 3 |
NVIDIA
NVDA
|
+$233M |
| 4 |
Cadence Design Systems
CDNS
|
+$222M |
| 5 |
CSX Corp
CSX
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.46% |
| 2 | Healthcare | 15.52% |
| 3 | Financials | 13.32% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
State Street
STT
$50.9B
| $64M | 0.04% |
656,067
+196,429
| +43% | +$18.8M |
|
|
SYNH
477
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $64M | 0.04% |
1,468,588
+124,657
| +9% | +$5.82M |
|
478
Exelon
EXC
$48.6B
| $63.9M | 0.04% |
2,272,325
-165,194
| -7% | -$4.75M |
|
479
Aflac
AFL
$63.9B
| $63.6M | 0.04% |
1,449,988
-155,824
| -10% | -$6.65M |
|
480
Unum
UNM
$13.8B
| $63.5M | 0.04% |
1,156,481
-551,515
| -32% | -$29.6M |
|
|
ISBC
481
DELISTED
Investors Bancorp, Inc.
ISBC
| $63.3M | 0.04% |
4,559,776
+7,705
| +0.2% | +$107K |
|
482
NorthWestern Energy
NWE
$4.48B
| $63.3M | 0.04% |
1,059,987
+248,412
| +31% | +$15M |
|
483
Cognex
CGNX
$10.3B
| $62.9M | 0.04% |
1,029,067
-241,969
| -19% | -$15.4M |
|
484
Cohen & Steers
CNS
$4.18B
| $62.8M | 0.04% |
1,328,884
-114,191
| -8% | -$5.03M |
|
485
CVS Health
CVS
$137B
| $62.7M | 0.04% |
864,913
-26,524
| -3% | -$1.93M |
|
486
Alnylam Pharmaceuticals
ALNY
$36.3B
| $62.7M | 0.04% |
493,619
-189,401
| -28% | -$23.8M |
|
487
UDR
UDR
$12.9B
| $62.6M | 0.04% |
1,624,849
+1,068
| +0.1% | +$41.5K |
|
488
Tyson Foods
TSN
$20.2B
| $61.8M | 0.04% |
762,450
-725,130
| -49% | -$55.5M |
|
489
ManpowerGroup
MAN
$2.39B
| $61.8M | 0.04% |
489,865
+111,600
| +30% | +$13.9M |
|
|
WMGI
490
DELISTED
Wright Medical Group Inc
WMGI
| $61.6M | 0.04% |
2,774,943
+284,208
| +11% | +$7.01M |
|
491
West Pharmaceutical
WST
$23.1B
| $61.4M | 0.04% |
622,458
+113,227
| +22% | +$11.1M |
|
492
Jack in the Box
JACK
$278M
| $60.9M | 0.04% |
620,893
-2,216
| -0.4% | -$225K |
|
493
Fomento Económico Mexicano
FMX
$43.3B
| $60.9M | 0.04% |
+648,074
| New | +$59.1M |
|
494
Collegium Pharmaceutical
COLL
$1.14B
| $60.8M | 0.04% |
+3,292,058
| New | +$47.2M |
|
495
Blackrock
BLK
$164B
| $60.7M | 0.04% |
118,209
+1,714
| +1% | +$833K |
|
496
Merit Medical Systems
MMSI
$4.43B
| $60.6M | 0.04% |
1,403,444
-119,933
| -8% | -$5.03M |
|
497
RBC Bearings
RBC
$18.8B
| $60.6M | 0.04% |
479,220
+76,523
| +19% | +$9.6M |
|
|
COL
498
DELISTED
Rockwell Collins
COL
| $60.5M | 0.04% |
446,270
+197,432
| +79% | +$26.5M |
|
|
VMW
499
DELISTED
VMware, Inc
VMW
| $60.4M | 0.04% |
482,140
-71,650
| -13% | -$8.6M |
|
|
CMD
500
DELISTED
Cantel Medical Corporation
CMD
| $60.2M | 0.04% |
585,042
+207,388
| +55% | +$20.7M |
|
Similar funds
Janus Henderson Group's Q4 2017 Portfolio in Review
As of Q4 2017, Janus Henderson Group held 1,379 positions worth $165B, up 5.4% from $156B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q4 2017 filing shows 95 new, 535 increased, 621 reduced and 76 closed positions. Its largest new stake was Invitation Homes: 5,558,350 shares worth $131M. The largest sale was Lowe's Companies, an estimated $279M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2017 buy was Invitation Homes: 5,558,350 shares worth $131M.
- Janus Henderson Group added most to Puma Biotechnology in Q4 2017, an estimated $276M increase.
- Janus Henderson Group's biggest Q4 2017 reduction was Lowe's Companies, cutting an estimated $279M.
- Janus Henderson Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $124M.
- Janus Henderson Group's ten largest holdings make up 14% of its $165B portfolio in Q4 2017.
- Janus Henderson Group opened 95 new positions and closed 76 in Q4 2017.
- Janus Henderson Group's portfolio value rose 5.4% quarter-over-quarter to $165B.
Based on Janus Henderson Group's 13F filing for Q4 2017, filed 9 Feb 2018.